Anaptysbio (ANAB) Other Non Operating Income (2016 - 2026)
Anaptysbio posted quarterly Other Non Operating Income of -$1000.0 for Q1 2026, down 100.05% year-on-year from $1.9 million in Q1 2025, and up 66.67% on a QoQ basis from -$3000.0 in Q4 2025.
Anaptysbio (ANAB) has 11 years of Other Non Operating Income data on file, last reported at -$1000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 100.05% year-over-year to -$1000.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 83.89% YoY), and the FY2025 full-year result was $5.4 million, up 38685.71% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$1000.0, up from -$3000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $3.5 million in Q2 2025 and bottomed at -$5000.0 in Q3 2024.
- The 5-year median for Other Non Operating Income is $1000.0 (2023), against an average of $363533.3.
- The widest annual swing landed in 2024, when Other Non Operating Income sank 600.0%; it then soared 95200.0% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at -$4000.0 in 2022, then surged by 50.0% to -$2000.0 in 2023, then jumped by 1150.0% to $21000.0 in 2024, then sank by 114.29% to -$3000.0 in 2025, then jumped by 66.67% to -$1000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$1000.0 (Q1 2026), -$3000.0 (Q4 2025), and $3.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Jun 30, 2025 | 3.53 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | -75,000.00 |
| Sep 30, 2020 | -56,000.00 |
| Jun 30, 2020 | 26,000.00 |
| Mar 31, 2020 | 94,000.00 |
| Dec 31, 2019 | -109,000.00 |
| Sep 30, 2019 | 144,000.00 |
| Jun 30, 2019 | -41,000.00 |
| Mar 31, 2019 | 7,000.00 |
| Dec 31, 2018 | 8,000.00 |
| Sep 30, 2018 | -40,000.00 |
| Jun 30, 2018 | -64,000.00 |
| Mar 31, 2018 | -63,000.00 |
| Dec 31, 2017 | -115,000.00 |
| Sep 30, 2017 | 91,000.00 |
| Jun 30, 2017 | 29,000.00 |
| Mar 31, 2017 | 225,000.00 |
| Dec 31, 2016 | -329,000.00 |
| Sep 30, 2016 | 123,000.00 |
| Jun 30, 2016 | 72,000.00 |
| Mar 31, 2016 | -13,000.00 |